Interplay of m 6 A and histone modifications contributes to temozolomide resistance in glioblastoma-Reference-Cited by-同舟云学术

Interplay of m 6 A and histone modifications contributes to temozolomide resistance in glioblastoma

Published:2021-09 Issue:9 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Li Fuxi¹²³,Chen Siyun³,Yu Jiaming³,Gao Zhuoxing²,Sun Zhangyi³,Yi Yang³,Long Teng³,Zhang Chuanxia²,Li Yuzhe⁴,Pan Yimin⁴,Qin Chaoying⁴,Long Wenyong⁴,Liu Qing⁴,Zhao Wei²^ORCID

Affiliation:

1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center Sun Yat‐sen University Guangzhou China

2. Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou China

3. Key Laboratory of Stem Cells and Tissue Engineering, Sun Yat‐Sen University, Ministry of Education Guangzhou China

4. Neurosurgery Department, Xiangya Hospital Central South University Changsha China

Funder

National Natural Science Foundation of China

Guangdong Province Introduction of Innovative R&D Team

National Basic Research Program of China

Natural Science Foundation of Guangdong Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.553

Reference42 articles.

1. Malignant Gliomas in Adults

2. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012;Ostrom QT;Neuro‐oncology,2015

3. High‐grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow‐up;Stupp R;Ann Oncol,2014

4. Tumor treating fields: a novel treatment modality and its use in brain tumors

5. MGMT: its role in cancer aetiology and cancer therapeutics

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of N6‐methyladenosine RNA modification in cancer;MedComm;2024-09

2. UBE2D3 regulated by WTAP-mediated m6A modification inhibits temozolomide chemosensitivity in glioblastoma;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-01

3. A m6A regulators-related classifier for prognosis and tumor microenvironment characterization in hepatocellular carcinoma;Frontiers in Immunology;2024-07-25

4. Lineage specification in glioblastoma is regulated by METTL7B;Cell Reports;2024-06

5. ADAR1 promotes cisplatin resistance in intrahepatic cholangiocarcinoma by regulating BRCA2 expression through A‐to‐I editing manner;Cell Proliferation;2024-05-21